Skip to main content
Conference Preview

First Annual ADCD Symposium to ‘Bridge the Gap’ in Alzheimer Disease Education

The first annual Alzheimer’s Disease and Cognitive Disorders (ADCD) Symposium will convene virtually next week on November 12 and 13, 2025. The CME event is designed for a wide variety of healthcare professionals who care for patients with neurologic and cognitive disorders, including neurologists, psychiatrists, primary care providers, geriatricians, nurse practitioners, physician assistants, and nurses. Additionally, the event is free to attend for providers and other industry members.

Featuring 6 sessions presented by leading experts in neurology, psychiatry, and primary care, the ADCD Symposium seeks to “close persistent gaps in Alzheimer’s care” by exploring topics including timely diagnosis, disease-modifying therapies, neuropsychiatric management, and caregiver strategies.

“The multidisciplinary faculty for this program comprises every aspect of care for this challenging group of illnesses, from bench researchers to primary care clinicians to subspecialty experts, to families and caregiver partners,” said W. Clay Jackson, MD, DipTh, Co-Chair of the ADCD Symposium. “The interchange of information and expertise we shared in putting together the program left each of us feeling enriched and challenged—I know attendees will feel the same as they take advantage of these clinical pearls and exciting innovations to ‘level up’ in their care of their patients!”

>>CONFERENCE COVERAGE: Introducing the Alzheimer's Disease and Cognitive Disorders Symposium

One of the sessions, “Whole-Person, Whole-Team: Integrating Caregivers into the Alzheimer’s Treatment Continuum,” will bring together Dr Jackson alongside Ipsit Vahia, MD, Chief of Geriatric Psychiatry at Harvard Medical School; Mary Perkins, a caregiver; and Nichole Goble, Directory of Community Initiatives at the Caregiver Action Network. Together, the panel will explore collaborative approaches to caregiver support, as well as discuss what each member of the healthcare team can do to ease the burden on caregivers and promote their deeper engagement across the care continuum.

Another session of note is “Bringing It All Together: Practical Cases in Alzheimer’s Diagnosis and Management,” presented by Dr Jackson and fellow ADCD Symposium Co-Chairs Marc Agronin, MD, and Marwan Sabbagh, MD, FAAN, FANA. The case-based session will delve into the nuances of real-world Alzheimer’s care, including how to navigate diagnosis, treatment decisions, and caregiver coordination through assessment tools, biomarker interpretation, therapeutic planning, and handling behavioral symptoms.

"As clinicians, we know that Alzheimer’s disease management rarely follows a simple script,” said Dr Sabbagh. “This session is designed to mirror the complexity of real-world practice—where diagnostic uncertainty, evolving biomarkers, and challenging behavioral symptoms intersect.”

“My hope is that attendees come away with a more integrated approach to care, one that combines emerging science with the everyday realities of patients and families.”

For more information about and to register for the Alzheimer’s Disease and Cognitive Disorders Symposium, visit the meeting website.